Dr Andrew Belcher’s current role in ADePT is working on the PATHWAY-Beacons study which aims to determine if it is feasible to roll out Group-MCT in cardiac rehabilitation services across the NHS. As a National Institute for Health Research (NIHR)-funded study, this research has significant implications for mental health care.
In addition to this work, Andrew is also involved in The Youth Metacognitive Therapy (YoMeta) trial, which aims to investigate the effectiveness of group metacognitive therapy (MCT) for children and young people with anxiety and depression.
Dr Andrew Belcher has a background in Biomedical Sciences, Clinical Neurology, and Medicine provides valuable perspectives on physical and mental health interplay, particularly in neurological disorders. During his PhD research, Andrew investigated the risk factors associated with short and long-term cognitive impairment in people who have experienced a stroke or have multiple sclerosis. This research helps in understanding the cognitive and psychological impact of neurological disorders, highlighting the need for a holistic approach to care.